Registration is now open for the virtual event Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway in Sweden, taking place virtually on 26 September 2023 at 09:00 – 11:00 CET.

About Alzheimer’s disease

Alzheimer’s disease (AD) is a neurodegenerative disease that progresses in stages, beginning with a long silent phase before symptoms occur. It is the underlying cause in 70% of people with dementia. Dementia, which is not a specific disease but an overall term that describes a group of symptoms, is characterised by a decline in memory, thinking, behaviour and the ability to perform everyday activities.

It is estimated that 7 million people in Europe alone already live with Alzheimer’s disease and dementia. With a rapidly ageing population, it is a growing public health concern worldwide as this number is projected to rise to a staggering 14 million by 2030.

Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway

The virtual event follows the launch of the Rethinking Alzheimer’s Disease White Paper: Detection & Diagnosis, looking at how to detect and diagnose the disease at an earlier stage (at mild cognitive impairment – MCI  – stage) and what new care pathways would need to be implemented to reach out to patients at that stage. Furthermore, with disease modifying treatments targeting patients with MCI potentially coming to market in the near future, it is important to see how prepared healthcare systems are to provide these new treatments.  

The programme will feature keynote speeches on daily life living with Alzheimer’s disease and how we can rethink the Alzheimer’s care pathway, a panel discussion featuring key opinion leaders and experts involved in the Rethinking Alzheimer’s disease project, and much more. 

** Discover the programme **

All participants must register before attending this event. Once registered, Zoom instructions will be sent via email closer to the date.